| Mean age (SD) | | 55.5 (12.6) | 54.2 (12.5) | 58.8 (13.2) | 53.6 (10.2) | 0.459 |
| | % | % | % | % | |
| Sex | Men | 19.0 | 23.1 | 43.8 | 43.9 | 0.090 |
| Women | 81.0 | 76.9 | 56.2 | 57.1 | |
| RA duration | > median | 51.8 | 50.3 | 43.8 | 28.6 | 0.651 |
| ≤ median | 48.2 | 49.7 | 56.2 | 71.4 | |
| Satisfaction | | | | | | |
| Symptoms control | Very/quite satisfied | 93.1 | 82.9 | 68.8 | 85.7 | 0.009 |
| Indifferent, quite/very unsatisfied | 6.9 | 17.1 | 31.2 | 14.3 | |
| Tolerance/side effects | Very/quite satisfied | 79.7 | 57.0 | 50.0 | 57.1 | <0.001 |
| Indifferent, quite/very unsatisfied | 20.3 | 43.0 | 50.0 | 42.9 | |
| Expectations | | | | | | |
| Effect of the drug on symptoms | Much/quite greater than expected | 69.6 | 53.3 | 75.0 | 57.1 | 0.031 |
| +/− As expected | 23.5 | 39.0 | 12.5 | 28.6 | |
| Quite/lower than expected | 7.0 | 7.7 | 12.5 | 14.3 | |
| Side effects/discomfort | Much/quite greater than expected | 7.0 | 17.0 | 12.5 | 0.0 | 0.004 |
| +/− As expected | 27.0 | 39.6 | 25.0 | 57.1 | |
| Quite/lower than expected, or no side effects/discomfort | 66.0 | 43.4 | 62.5 | 42.9 | |